1253.4000 -18.00 (-1.42%)
NSE Jan 01, 2026 15:49 PM
Volume: 553.8K
 

1253.40
-1.42%
ICICI Direct
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Motilal Oswal released a Neutral report for Dr. Reddy's Laboratories Ltd. with a price target of 1250.0 on 12 Dec, 2025.
More from Dr. Reddy's Laboratories Ltd.
Recommended